title: Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
authors.forename: C M
authors.initials: CM
authors.lastname: Mastroianni
authors.forename: G
authors.initials: G
authors.lastname: d'Ettorre
authors.forename: G
authors.initials: G
authors.lastname: Forcina
authors.forename: M
authors.initials: M
authors.lastname: Lichtner
authors.forename: A
authors.initials: A
authors.lastname: Corpolongo
authors.forename: S
authors.initials: S
authors.lastname: Coletta
authors.forename: V
authors.initials: V
authors.lastname: Vullo
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D017320:HIV Protease Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil